Targeting macrophages to treat pancreatic cancer growth and metastasis

This research project will define the therapeutic benefit of targeting Haematopoietic Cell Kinase (HCK) in advanced-stage pancreatic cancer. This aims is to provide novel molecular insights into therapeutically targetable mechanisms by which macrophages promote pancreatic cancer progression, and deliver better therapeutic options to pancreatic cancer patients.